Top Industry Leaders in the Healthcare Bioconvergence Market
Latest Healthcare Bioconvergence Companies Update:
BiomX (microbiome therapeutics) Received a Therapeutics Development Award of up to $5 million from the Cystic Fibrosis Foundation to develop phage therapies for cystic fibrosis.
Century Therapeutics (cell therapy) Collaborated with Bristol Myers Squibb to commercialize IPSC-derived allogenic cell-based therapies, strengthening their position in personalized medicine.
Abu Dhabi Department of Health and Israel Innovation Authority Partnered to work on critical health innovation projects, including proof-of-concept and clinical trials.
Life Arc (UK medical research firm) Funded $5.74 million for the Gen OMICC COVID-19 project, supporting patient enrollment, sample collection, and bioinformatics analysis.
List of Healthcare Bioconvergence Key companies in the market
- Ginkgo Bioworks (US)
- Thermo Fisher Scientific Inc. (US)
- GE Healthcare (US)
- Siemens (Germany)
- BiomX (Israel)
- Century Therapeutics (US)
- Singota Solutions (US)
- Galvani Bioelectronics (UK)
- Bico Group (US)
- SetPoint Medical (US)